$49.00
USD
Research Use Only (RUO) • Not for Human or Veterinary Use • Not for Consumption.
PT-141, commonly referenced as bremelanotide peptide, is a synthetic melanocortin receptor agonist used in controlled research workflows to investigate receptor-mediated signaling and downstream pathway readouts in non-clinical models. This page provides laboratory context only and does not imply clinical outcomes.
| Product Name | PT-141 (Bremelanotide) |
|---|---|
| CAS Number | 189691-06-3 |
| Molecular Formula | C50H68N14O10 |
| Molecular Weight | ~1025.2 g/mol |
| Peptide Type | Cyclic melanocortin receptor research peptide |
| Purity | ≥99% (HPLC verified) |
| Verification | HPLC / MS tested (batch-based) |
| Physical Form | Lyophilized powder |
| Documentation | CoA available upon request |
| Grade | Research Use Only (RUO) |
Common queries include pt-141 peptide, bremelanotide, pt-141 bremelanotide, melanocortin receptor agonist, MC4R, MC3R, pt-141 lyophilized powder, pt-141 storage, and pt-141 reconstitution.
Below, those terms are addressed naturally through RUO-safe technical sections and FAQs (no medical claims).
In research literature, bremelanotide (PT-141) is discussed as a melanocortin-pathway probe, often evaluated for activity across melanocortin receptor subtypes (commonly referenced in CNS signaling models). Researchers use PT-141 to explore receptor binding, cAMP signaling, and pathway-level modulation under defined experimental conditions.
PT-141 is widely referenced for melanocortin receptor pathway investigation, supporting assays that quantify receptor activation and downstream signaling readouts (e.g., cAMP-linked responses) in controlled in-vitro systems. Experimental design, receptor subtype selection, and endpoints are protocol-dependent.
For pt-141 storage and preparation in RUO workflows, follow your laboratory SOP and the product documentation. Many labs store lyophilized peptides cold, protected from light and moisture, and prepare solutions only as needed for assays.
PT-141 (bremelanotide) is a melanocortin-pathway research peptide used in non-clinical workflows to study receptor signaling (e.g., MC4R/MC3R) and downstream mechanistic readouts in controlled systems.
No. Peptides Skin supplies PT-141 strictly as Research Use Only (RUO). It is not intended or approved for human or veterinary use, injection, or consumption.
Common references list CAS 189691-06-3 and a molecular weight of approximately ~1025.2 g/mol for bremelanotide (PT-141). Always verify against batch documentation for your laboratory records.
Store lyophilized PT-141 at −20°C or below, protected from light and moisture. Follow your SOP and minimize freeze–thaw cycles to reduce experimental variability.
Yes. CoA is available upon request, with batch-based HPLC purity verification and MS identity support for qualified research customers.